The high expression of disulfidptosis genes (e.g., SLC3A2, RPN1, BRK1, ACTR2, ACTR3, SLC7A11, and NCKAP1) in the KM analysis of breast cancer indicated the poor prognosis of patients. This evidence concerns the gene ACTR3 and breast carcinoma.